These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21525304)

  • 1. Disulfide-mediated oligomer formation in Borrelia burgdorferi outer surface protein C, a critical virulence factor and potential Lyme disease vaccine candidate.
    Earnhart CG; Rhodes DV; Marconi RT
    Clin Vaccine Immunol; 2011 Jun; 18(6):901-6. PubMed ID: 21525304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal disulfide-bridging of Borrelia outer surface protein C increases its diagnostic and vaccine potentials.
    Probst C; Ott A; Scheper T; Meyer W; Stöcker W; Komorowski L
    Ticks Tick Borne Dis; 2012 Feb; 3(1):1-7. PubMed ID: 22309852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tick-Tattoo: DNA Vaccination Against
    Klouwens MJ; Trentelman JJA; Wagemakers A; Ersoz JI; Bins AD; Hovius JW
    Front Immunol; 2021; 12():615011. PubMed ID: 33717102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the potential contribution of the highly conserved C-terminal motif (C10) of Borrelia burgdorferi outer surface protein C in transmission and infectivity.
    Earnhart CG; Rhodes DV; Smith AA; Yang X; Tegels B; Carlyon JA; Pal U; Marconi RT
    Pathog Dis; 2014 Mar; 70(2):176-84. PubMed ID: 24376161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.
    Edmondson DG; Prabhakaran S; Norris SJ; Ullmann AJ; Piesman J; Dolan M; Probst C; Radzimski C; Stöcker W; Komorowski L
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27733423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific immune response to a synthetic peptide derived from outer surface protein C of Borrelia burgdorferi predicts protective borreliacidal antibodies.
    Ikushima M; Matsui K; Yamada F; Kawahashi S; Nishikawa SK
    FEMS Immunol Med Microbiol; 2000 Sep; 29(1):15-21. PubMed ID: 10967255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic analysis of outer surface protein C (OspC) of Borrelia burgdorferi sensu lato by monoclonal antibodies: relationship to genospecies and OspA serotype.
    Wilske B; Jauris-Heipke S; Lobentanzer R; Pradel I; Preac-Mursic V; Rössler D; Soutschek E; Johnson RC
    J Clin Microbiol; 1995 Jan; 33(1):103-9. PubMed ID: 7699024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Borrelia burgdorferi ospC genotypes in canine tissue following tick infestation: implications for Lyme disease vaccine and diagnostic assay design.
    Rhodes DV; Earnhart CG; Mather TN; Meeus PF; Marconi RT
    Vet J; 2013 Nov; 198(2):412-8. PubMed ID: 23962611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An octavalent lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences.
    Earnhart CG; Marconi RT
    Hum Vaccin; 2007; 3(6):281-9. PubMed ID: 17921702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of residues within ligand-binding domain 1 (LBD1) of the Borrelia burgdorferi OspC protein required for function in the mammalian environment.
    Earnhart CG; Leblanc DV; Alix KE; Desrosiers DC; Radolf JD; Marconi RT
    Mol Microbiol; 2010 Apr; 76(2):393-408. PubMed ID: 20199597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoblot using recombinant antigens derived from different genospecies of Borrelia burgdorferi sensu lato.
    Wilske B; Fingerle V; Preac-Mursic V; Jauris-Heipke S; Hofmann A; Loy H; Pfister HW; Rössler D; Soutschek E
    Med Microbiol Immunol; 1994 Feb; 183(1):43-59. PubMed ID: 8202030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Elucidation of a Protective B Cell Epitope on Outer Surface Protein C (OspC) of the Lyme Disease Spirochete, Borreliella burgdorferi.
    Rudolph MJ; Davis SA; Haque HME; Weis DD; Vance DJ; Piazza CL; Ejemel M; Cavacini L; Wang Y; Mbow ML; Gilmore RD; Mantis NJ
    mBio; 2023 Apr; 14(2):e0298122. PubMed ID: 36976016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis.
    Panelius J; Lahdenne P; Heikkilä T; Peltomaa M; Oksi J; Seppälä I
    J Med Microbiol; 2002 Sep; 51(9):731-739. PubMed ID: 12358063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi.
    Rousselle JC; Callister SM; Schell RF; Lovrich SD; Jobe DA; Marks JA; Wieneke CA
    J Infect Dis; 1998 Sep; 178(3):733-41. PubMed ID: 9728542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development.
    Oliver LD; Earnhart CG; Virginia-Rhodes D; Theisen M; Marconi RT
    Vet J; 2016 Dec; 218():27-33. PubMed ID: 27938705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
    Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
    Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection.
    Fung BP; McHugh GL; Leong JM; Steere AC
    Infect Immun; 1994 Aug; 62(8):3213-21. PubMed ID: 8039891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.
    Pal U; Montgomery RR; Lusitani D; Voet P; Weynants V; Malawista SE; Lobet Y; Fikrig E
    J Immunol; 2001 Jun; 166(12):7398-403. PubMed ID: 11390491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responses.
    Scheiblhofer S; Weiss R; Dürnberger H; Mostböck S; Breitenbach M; Livey I; Thalhamer J
    Microbes Infect; 2003 Sep; 5(11):939-46. PubMed ID: 12941385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC.
    Gilmore RD; Kappel KJ; Dolan MC; Burkot TR; Johnson BJ
    Infect Immun; 1996 Jun; 64(6):2234-9. PubMed ID: 8675332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.